SAN DIEGO, Jan. 4, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that Raul Elizalde, President of subsidiary HempMeds® Mexico, has been promoted to President, Latin America for the company.
Elizalde, who joined Medical Marijuana, Inc. and HempMeds® Mexico in June 2017, was an active medical cannabis advocate prior to joining the Company because of his fight to gain access to CBD hemp oil for his daughter Grace, who suffers from epilepsy. Elizalde’s fight led to the legalization of medical cannabis in Mexico.
“We are proud of Raul’s many accomplishments over the past six months and we felt that it was time to give him more responsibility as our global operations continue to rapidly expand,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Since joining our organization, Raul has not only helped us grow our thriving Mexico market, but has also been a global voice for the Company to spread awareness regarding why CBD should be considered a supplement that can provide therapeutic benefits to people around the world.”
“I’m honored to be a part of the leading cannabis company and look forward to aggressive expansion of our company throughout Latin America,” said HempMeds® President, Latin America, Raul Elizalde.
In Nov. 2017, Elizalde was invited to speak to the World Health Organization at the Expert Committee on Drug Dependence Conference in Geneva, Switzerland. There, he presented evidence that cannabidiol (CBD) is not psychoactive and does not have any side effects, eventually leading to the committee’s recommendation not to schedule CBD as a drug.
Elizalde is also the founder of not-for-profit organization Por Grace Foundation, which he established to ensure families receive the right to health care and access to CBD hemp oil and to advocate for medical marijuana legalization in Mexico.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact: